Mubadala Investment Co PJSC, 10% Owner at RECURSION PHARMACEUTICALS, INC. (RXRX), bought 126,764 shares at $7.71 ($977K) on 2023-02-17, disclosed to the SEC on 2023-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.71 | 63,382 | $489K | 50.0% |
| 2 | $7.71 | 63,382 | $489K | 50.0% |
| Total | $7.71 avg | 126,764 | $977K | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateMidCap Apollo Institutional Private Lending | BUY | 2025-09-11 | $86.5M | — | Filing → |
| PrivateMidCap Apollo Institutional Private Lending | BUY |
| 2025-07-31 |
| $37.4M |
| — |
| Filing → |
| RXRX | BUY | 2023-03-03 | $1.0M | — | Filing → |
| RXRX | BUY | 2023-03-02 | $776K | — | Filing → |
| RXRX | BUY | 2023-03-01 | $6K | — | Filing → |